Boston Scientific Corp. has joined a crowded European transcatheter aortic heart valve replacement market with the launch of its Lotus TAVR system at select centers. The firm announced the CE mark and initial limited launch of the device Oct. 28, with plans to accelerate commercial site expansion as physicians and centers become fully trained.
Edwards Lifesciences Corp.’s Sapien and Medtronic PLC’s CoreValve lead the European TAVR market, but at least five other...